Pristimerin inhibits glioma progression by targeting AGO2 and PTPN1 expression via miR-542-5p Zaiyu Li et al, 2019, Bioscience Reports CrossRef
Anti-Cancer Effects of Pristimerin and the Mechanisms: A Critical Review Jia-jun Li et al, 2019, Frontiers in Pharmacology CrossRef
Pristimerin in Oxidative Stress and Use in Cancer Ana Carolina B. da C. Rodrigues et al, 2021, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
The plant-derived triterpenoid tingenin B is a potent anticancer agent due to its cytotoxic activity on cancer stem cells of breast cancer in vitro Buse Cevatemre et al, 2016, Chemico-Biological Interactions CrossRef
ATTEMPTS TO SYNTHESIZE A TRIMERIC DERIVATIVE OF PRISTIMERIN WITH POTENTIAL ACTIVITY AGAINST CANCER CELLS Josana Pereira Dos Santos et al, 2024, Revista Contemporânea CrossRef
Pristimerin effectively inhibits the malignant phenotypes of uveal melanoma cells by targeting NF-κB pathway Biao Zhang et al, 2017, International Journal of Oncology CrossRef
Pristimerin enhances the effect of cisplatin by inhibiting the miR‑23a/Akt/GSK3β signaling pathway and suppressing autophagy in lung cancer cells Yingbing Zhang et al, 2019, International Journal of Molecular Medicine CrossRef
Pristimerin Suppresses Trophoblast Cell Epithelial–Mesenchymal Transition via miR-542-5p/EGFR Axis
Chang Shu et al, 2020, Drug Design, Development and Therapy CrossRef
Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances Run-Ze Chen et al, 2021, Frontiers in Oncology CrossRef
A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer Buse Cevatemre et al, 2018, Pharmacological Research CrossRef
Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant Elaine C. D. Gonçalves et al, 2020, Molecules CrossRef
Zhankuic Acids A, B and C from Taiwanofungus camphoratus Act as Cytotoxicity Enhancers by Regulating P-Glycoprotein in Multi-Drug Resistant Cancer Cells Yu-Ning Teng et al, 2019, Biomolecules CrossRef
Pristimerin in Oxidative Stress and Use in Cancer Ana Carolina B. da C. Rodrigues et al, 2022, Handbook of Oxidative Stress in Cancer: Therapeutic Aspects CrossRef
Pristimerin induces apoptosis of oral squamous cell carcinoma cells via G1 phase arrest and MAPK/Erk1/2 and Akt signaling inhibition Haiyan Wu et al, 2019, Oncology Letters CrossRef
Pristimerin Suppressed Breast Cancer Progression via miR-542-5p/DUB3 Axis
Shihuan Cheng et al, 2020, OncoTargets and Therapy CrossRef